EP Patent

EP4057996B1 — Amorphous pharmaceutical compositions of abiraterone acetate

Assigned to Suven Life Sciences Ltd · Expires 2023-07-12 · 3y expired

What this patent protects

Patent listed against rolapitant-hydrochloride.

Drugs covered by this patent

rolapitant-hydrochloride (ROLAPITANT HYDROCHLORIDE)

Patent Metadata

Patent number: EP4057996B1
Jurisdiction: EP
Classification: —
Expires: 2023-07-12
Drug substance claim: No
Drug product claim: No
Assignee: Suven Life Sciences Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.